Technical Analysis for CORT - Corcept Therapeutics Incorporated

Grade Last Price % Change Price Change
F 20.02 -0.60% -0.12
CORT closed down 0.6 percent on Tuesday, July 27, 2021, on approximately normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
Earnings due: Aug 2
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical CORT trend table...

Date Alert Name Type % Chg
Hammer Candlestick Bullish 0.00%
Multiple of Ten Bullish Other 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Down 3 Days in a Row Weakness -0.60%
Oversold Stochastic Weakness -0.60%
Stochastic Reached Oversold Weakness -1.33%
Oversold Stochastic Weakness -1.33%
180 Bearish Setup Bearish Swing Setup -1.48%
Older End-of-Day Signals for CORT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 12 hours ago
Down 2 % about 12 hours ago
Down 1% about 13 hours ago
Fell Below Previous Day's Low about 13 hours ago
Down 1% 1 day ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Corcept Therapeutics Incorporated Description

Corcept Therapeutics Incorporated, a pharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of severe metabolic and psychiatric disorders in the United States. The company focuses on disorders that are associated with a steroid hormone called cortisol. It offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. The company is also involved in an on-going Phase III study of mifepristone, the active ingredient in Korlym, for treatment of the psychotic features of psychotic depression. In addition, it discovers and develops three series of novel selective GR-II antagonists. The company has research and development agreements with Argenta Discovery Limited; Sygnature Discovery Limited; ICON Clinical Research, L.P.; and MedAvante, Inc. as well as has a patent license from Stanford University for developing mifepristone. Corcept Therapeutics Incorporated was founded in 1998 and is headquartered in Menlo Park, California.


Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Organ Systems Surgery Diabetes Clinical Research Disorders Glucose Endocrine System Hormones Depression Diabetes Mellitus Psychiatric Disorders Cushing's Syndrome Hyperglycemia Stanford University Cortisol Endogenous Cushing's Syndrome

Is CORT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 31.18
52 Week Low 12.2
Average Volume 523,700
200-Day Moving Average 23.27
50-Day Moving Average 21.60
20-Day Moving Average 21.22
10-Day Moving Average 20.37
Average True Range 0.55
ADX 23.52
+DI 12.60
-DI 31.15
Chandelier Exit (Long, 3 ATRs) 21.48
Chandelier Exit (Short, 3 ATRs) 21.30
Upper Bollinger Bands 23.00
Lower Bollinger Band 19.45
Percent B (%b) 0.16
BandWidth 16.72
MACD Line -0.52
MACD Signal Line -0.40
MACD Histogram -0.1235
Fundamentals Value
Market Cap 2.33 Billion
Num Shares 116 Million
EPS 0.89
Price-to-Earnings (P/E) Ratio 22.49
Price-to-Sales 8.08
Price-to-Book 5.54
PEG Ratio 0.61
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 20.79
Resistance 3 (R3) 20.75 20.46 20.66
Resistance 2 (R2) 20.46 20.27 20.48 20.61
Resistance 1 (R1) 20.24 20.14 20.10 20.28 20.57
Pivot Point 19.95 19.95 19.88 19.97 19.95
Support 1 (S1) 19.73 19.76 19.59 19.77 19.47
Support 2 (S2) 19.44 19.63 19.46 19.43
Support 3 (S3) 19.22 19.44 19.38
Support 4 (S4) 19.26